Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2009 Aug 28;241(2):143–153. doi: 10.1016/j.taap.2009.08.021

Figure 8. The tyrosine phosphatase inhibitor sodium orthovanadate does not mimic the effect of palytoxin on ERK5.

Figure 8

HeLa and 308 cells were incubated for the indicated times with 1 mM sodium orthovanadate. Protein (20 μg) from whole cell lysates was analyzed by immunoblot for the following: ERK5; phosphorylated, active ERK1/2 (pERK1 and pERK2); and total ERK2. The data shown are representative of at least two independent experiments.